Archive for January 2022

Firebrick launch on ASX receives national media attention

Firebrick Pharma to debut on the ASX

Firebrick Pharma will be listed on the Australian Securities Exchange (ASX) from 12:30pm AEDT on Friday, 28 January. The Company’s flagship product, Nasodine® Nasal Spray (“Nasodine”) kills respiratory viruses and has already completed one Phase 3 clinical trial as a treatment for the common cold*. In 2022, the Company plans to complete a second, confirmatory…